FxCycle™ Based Ploidy Correlates with Cytogenetic Ploidy in B‐Cell Acute Lymphoblastic Leukemia and Is Able to Detect the Aneuploid Minimal Residual Disease Clone

Authors:

Abstract
Background: Flow cytometry (FCM) is a simple, sensitive, and specific technique that can potentially determine DNA ploidy in B‐cell precursor ALL (BCP‐ALL) and is complementary to cytogenetics.Methods: A prospective FCM DNA ploidy analysis using FxCycle™ Violet (assay sensitivity 0.01%) was done in 125 consecutive new cases of BCP‐ALL (90 cases n= 56), low‐hyperdiploidy (DI 1.06 to 1.15) in 13.6% (n= 17), high‐hyperdiploidy (DI 1.16–1.39) in 32.8% (n= 41) and near‐tetraploidy (DI ≥ 1.80) in 2.4% (n= 3) cases. The high risk sub‐group of low‐hypodiploidy (DI 0.70 to 0.88)/near‐triploidy (DI 1.40 to 1.79) constituted 5.6% (n= 7) cases while there was only one case with haploidy (DI 0.58). Overall, high concordance of 90.4% (n= 113) was noted between the combined cytogenetics ploidy and FCM ploidy. Of the total discordant cases (n= 12), the maximum discordance was seen in the low‐hyperdiploid DI subgroup (n= 10), which included seven cases with low DNA index high hyperdiploidy (LDI‐HHD). FCM DNA ploidy assay was able to detect the residual clone in all six MRD positive aneuploid cases evaluated.Conclusions: FxCycle™ based DNA ploidy ascertains strong correlation with cytogenetic profiles and yields complementary information that can be used by the cytogenetics laboratories or otherwise. © 2019 International Clinical Cytometry Society
Funding Information
  • Department of Biotechnology , Ministry of Science and Technology (BT/PR12046/MED/12/665/2014‐reg)

This publication has 23 references indexed in Scilit: